Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Severe Acute Respiratory-Syndrome Treatment Market Covering 2025–2034?
The severe acute respiratory-syndrome treatment market size has experienced rapid growth in recent years. It is projected to expand from $3.45 billion in 2024 to $3.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.1%. This historical growth can be ascribed to elements like global outbreak response, antiviral drug development, vaccine development, and public health preparedness.
The severe acute respiratory-syndrome treatment market is projected for substantial expansion in the coming years. This market is anticipated to reach $7.08 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 15.8%. Key drivers for this growth during the forecast period include broad-spectrum antivirals, new therapeutic options, progress in vaccines, and enhanced pandemic readiness. Significant trends observed for the forecast duration encompass RNA-targeted therapies, the application of AI in drug discovery, worldwide collaborations, and improved public health education.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13027&type=smp
Which Industry Drivers Are Expected To Accelerate The Severe Acute Respiratory-Syndrome Treatment Market From 2025 To 2029?
The rising occurrence of respiratory diseases is anticipated to drive the future expansion of the severe acute respiratory syndrome treatment market. These conditions encompass various medical ailments impacting the respiratory system, which facilitates breathing and gas exchange between the body and its surroundings. Treatment for severe acute respiratory syndrome aims to ease symptoms, avert respiratory failure, diminish inflammation, and sustain adequate oxygen levels in individuals with respiratory illnesses. As an illustration, the National Asthma Council, an Australian non-profit focused on enhancing asthma care and management, reported in November 2023 that 467 asthma-related fatalities occurred in 2022, consisting of 299 females and 168 males. This number signifies an increase compared to the 355 deaths reported in 2021. Consequently, the escalating incidence of respiratory diseases is a key factor propelling the expansion of the severe acute respiratory syndrome treatment market.
What Are The Primary Types Of Segments Analyzed In The Severe Acute Respiratory-Syndrome Treatment Market?
The severe acute respiratory-syndrome treatmentmarket covered in this report is segmented –
1) By Drug Class: Antibiotics; Antiviral; Corticosteroids; Monoclonal Antibodies; Other Drug Classes
2) By Route Of Administration: Oral; Intravenous
3) By Indication: Severe Acute Respiratory Syndrome COVID-19 (SARS-CoV); Severe Acute Respiratory Syndrome COVID-19 2 (SARS-CoV-2)
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
Subsegments:
1) By Antibiotics: Broad-Spectrum Antibiotics; Narrow-Spectrum Antibiotics
2) By Antiviral: Nucleoside Analogs; Protease Inhibitors
3) By Corticosteroids: Systemic Corticosteroids; Inhaled Corticosteroids
4) By Monoclonal Antibodies: Neutralizing Antibodies; Non-Neutralizing Antibodies
5) By Other Drug Classes: Immunomodulators; Supportive Medications
What Long-Term Trends Will Shape The Future Growth Of The Severe Acute Respiratory-Syndrome Treatment Industry?
Leading companies in the severe acute respiratory syndrome treatment market are developing innovative techniques, such as multiplexed real-time PCR, to maintain their market position. This molecular biology technology, multiplexed real-time PCR, allows for the amplification and detection of numerous DNA or RNA targets in a single procedure. For instance, in July 2022, TransGen Biotech Co. Ltd., a Beijing-based researcher and manufacturer of molecular and cellular biology products, introduced the Trans-SARS-CoV-2, Influenza A and B and Respiratory Syncytial Virus Assay. This innovative assay is a multiplexed real-time PCR (polymerase chain reaction) assay designed to detect and differentiate between severe acute respiratory syndrome COVID-19 2 (SARS CoV 2), Influenza A, Influenza B, and respiratory syncytial virus (RSV) from a single specimen. Moreover, it represents a valuable tool for diagnosing and treating SARS, influenza, and RSV, which can contribute to guiding appropriate treatment and preventing the dissemination of these diseases.
Who Are The Primary Competitors In The Global Severe Acute Respiratory-Syndrome Treatment Market?
Major companies operating in the severe acute respiratory-syndrome treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Merck And Co Inc., Novartis AG, Bristol Myers Squib company, GlaxoSmithKline PLC, AstraZeneca PLC, Sanofi SA, Eli Lilly And Company, Gilead Sciences Inc., Amgen Inc., Johnson And Johnson Private Limited, Moderna Inc., Regeneron Pharmaceuticals Inc., Hetero labs Ltd., Alexion Pharmaceuticals Inc., Cadila healthcare Ltd., Genentech Inc., Cipla Ltd., Biogen Inc., Vir Biotechnology Inc., Swedish Orphan Biovitrum AB, Dynavax Technologies Corporation, ViiV Healthcare Limited, Panacea Biotec Limited, CureVac N.V., CN Bio Innovations Ltd., Inovio Pharmaceuticals Inc., Chimerix Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Severe Acute Respiratory-Syndrome Treatment Market?
North America was the largest region in the severe acute respiratory syndrome treatment market in 2024. Western Europe is expected to be the fastest-growing region in the forecast period. The regions covered in severe acute respiratory syndrome treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Severe Acute Respiratory-Syndrome Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=13027&type=smp
Browse Through More Reports Similar to the Global Severe Acute Respiratory-Syndrome Treatment Market 2025, By The Business Research Company
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Respiratory Disposables Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model